Characterize Spoil camouflage cd39 marker receive jog friendly

CD39, His-Tag (Human) Recombinant

Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies - ScienceDirect

The expression of the adenosine pathway markers CD39 and CD73 in salivary gland carcinomas harbors the potential for novel immune checkpoint inhibition | SpringerLink

CD39 is upregulated during activation of mouse and human T cells and attenuates the immune response to Listeria monocytogenes | PLOS ONE

JCI Insight - PD-1 blockade restores helper activity of tumor-infiltrating, exhausted PD-1hiCD39+ CD4 T cells

Genetically driven CD39 expression shapes human tumor‐infiltrating CD8+ T‐cell functions - Gallerano - 2020 - International Journal of Cancer - Wiley Online Library

Frontiers | What Else Can CD39 Tell Us?

The CD39+ HBV surface protein-targeted CAR-T and personalized tumor-reactive CD8+ T cells exhibit potent anti-HCC activity: Molecular Therapy

CD39/CD73: the critical targets for adenosinergic pathways - ACROBiosystems

Isolated CD39 Expression on CD4+ T Cells Denotes both Regulatory and Memory Populations - American Journal of Transplantation

Targeting CD39 in cancer | Nature Reviews Immunology

Recombinant Anti-CD39 antibody [EPR26473-58] (ab300065) | Abcam

IJMS | Free Full-Text | CD39 Regulation and Functions in T Cells

Adenosine-generating ovarian cancer cells attract myeloid cells which differentiate into adenosine-generating tumor associated macrophages – a self-amplifying, CD39- and CD73-dependent mechanism for tumor immune escape | Journal for ImmunoTherapy of Cancer

IJMS | Free Full-Text | CD39 Regulation and Functions in T Cells

On the mechanism of anti-CD39 immune checkpoint therapy | Journal for ImmunoTherapy of Cancer

The expression of the adenosine pathway markers CD39 and CD73 in salivary gland carcinomas harbors the potential for novel immune checkpoint inhibition | SpringerLink

Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors | Nature Communications

Phenotypical analysis of ectoenzymes CD39/CD73 and adenosine receptor 2A in CD4+CD25highFoxp3+ regulatory T‐cells in psoriasis - Han - 2018 - Australasian Journal of Dermatology - Wiley Online Library

CD39 Expression Identifies Terminally Exhausted CD8+ T Cells | PLOS Pathogens

PE-CF594 Mouse Anti-Human CD39

Frontiers | What Else Can CD39 Tell Us?

CD39 in the tumor immunity cycle. CD39 expression in tumors, lymph... | Download Scientific Diagram

CD39 was expressed variably but preferentially on memory Treg cells.... | Download Scientific Diagram